Literature DB >> 8102598

Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.

Y Himura1, S Y Felten, M Kashiki, T J Lewandowski, J M Delehanty, C S Liang.   

Abstract

BACKGROUND: We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to reduction of noradrenergic nerve terminals or whether these changes also occur in animals with left heart failure (LHF). It is also unknown whether increased NE release in heart failure contributes to the noradrenergic nerve abnormalities. METHODS AND
RESULTS: We measured myocardial NE content. NE uptake function, and noradrenergic nerve profiles in dogs with either RHF or LHF induced by rapid ventricular pacing. NE uptake activity was measured using [3H]NE, and noradrenergic nerve profiles were visualized by glyoxylic acid (SPG)-induced histofluorescence and tyrosine hydroxylase immunocytochemical staining. To study the effects of excess NE, we exposed normal dogs to 8 weeks of chronic NE infusion using subcutaneous osmotic minipumps. RHF and LHF animals exhibited reduced myocardial contractile function and congestive heart failure, as evidence by reduced cardiac output and elevated right atrial pressure. However, unlike that in LHF, left atrial pressure was not increased in RHF. The animals also showed an increase in plasma NE and a decrease in cardiac NE. In addition, SPG-induced histofluorescence correlated significantly with NE uptake activity (r = .712, P < .001) and tyrosine hydroxylase immunoreactive profiles (r = .569, P < .001) in the right ventricles of RHF dogs and in both ventricles of LHF dogs. The numbers of catecholaminergic profiles and tyrosine hydroxylase profiles significantly correlated with cardiac filling pressures. Chronic infusion of NE decreased heart rate in normal dogs but had no effect on either mean aortic pressure or left atrial pressure; like heart failure, it resulted in significant decreases in myocardial NE uptake activity and numbers of SPG-induced catecholaminergic histofluorescence and immunoreactive tyrosine hydroxylase profiles.
CONCLUSIONS: Myocardial NE uptake activity was reduced only in the failing ventricles with elevated filling pressure in RHF and LHF. These changes probably were caused by loss of noradrenergic nerve terminals in the failing ventricles, as evidenced by the reductions of catecholaminergic histofluorescence and tyrosine hydroxylase immunostained profiles. Furthermore, since similar reductions of myocardial NE uptake and noradrenergic nerve profiles could be produced by chronic NE infusion in normal dogs, elevated NE levels may play a role in the development of cardiac noradrenergic nerve abnormalities in congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102598     DOI: 10.1161/01.cir.88.3.1299

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.

Authors:  P Acar; P Merlet; L Iserin; D Bonnet; D Sidi; A Syrota; J Kachaner
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats.

Authors:  K Leineweber; T Seyfarth; O E Brodde
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Interleukin-17A increases neurite outgrowth from adult postganglionic sympathetic neurons.

Authors:  Susan P Chisholm; Andrea L Cervi; Simrin Nagpal; Alan E Lomax
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

4.  Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction.

Authors:  D Elizabeth Le; Eric R Powers; Jian-Ping Bin; Howard Leong-Poi; N Craig Goodman; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

5.  Expressions of cardiac sympathetic norepinephrine transporter and beta1-adrenergic receptor decreased in aged rats.

Authors:  He Li; Xiao-qing Ma; Fan Ye; Jing Zhang; Xin Zhou; Zhi-hong Wang; Yu-ming Li; Guo-yuan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

6.  Allometry of left ventricular myocardial innervation.

Authors:  Julia Schipke; Terry M Mayhew; Christian Mühlfeld
Journal:  J Anat       Date:  2013-12-10       Impact factor: 2.610

7.  Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.

Authors:  Ewa Soltysinska; Stefanie Thiele; Søren Peter Olesen; Oleg E Osadchii
Journal:  Pflugers Arch       Date:  2011-08-03       Impact factor: 3.657

Review 8.  The role of the autonomic nervous system in sudden cardiac death.

Authors:  Marmar Vaseghi; Kalyanam Shivkumar
Journal:  Prog Cardiovasc Dis       Date:  2008 May-Jun       Impact factor: 8.194

9.  Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts.

Authors:  Nina Kaludercic; Andrea Carpi; Takahiro Nagayama; Vidhya Sivakumaran; Guangshuo Zhu; Edwin W Lai; Djahida Bedja; Agnese De Mario; Kevin Chen; Kathleen L Gabrielson; Merry L Lindsey; Karel Pacak; Eiki Takimoto; Jean C Shih; David A Kass; Fabio Di Lisa; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2013-05-22       Impact factor: 8.401

10.  Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents.

Authors:  Hideaki Kanazawa; Masaki Ieda; Kensuke Kimura; Takahide Arai; Haruko Kawaguchi-Manabe; Tomohiro Matsuhashi; Jin Endo; Motoaki Sano; Takashi Kawakami; Tokuhiro Kimura; Toshiaki Monkawa; Matsuhiko Hayashi; Akio Iwanami; Hideyuki Okano; Yasunori Okada; Hatsue Ishibashi-Ueda; Satoshi Ogawa; Keiichi Fukuda
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.